1 completed, 1 not yet recruiting. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Bloating: new trials by email Literature Review of Bloating trials Research Report on Bloating
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders Rifaximin (drug), Placebo - Bloating, Rifaximin | Phase 3 | Not yet recruiting | Mahidol University | 78 | 2026-12-01 | 2026-10-27 |
| Probiotic Supplementation Among Adults With Recurrent Gastrointestinal Symptoms Probiotic dietary supplement (Trenev Trio®), placebo - Gastrointestinal Symptoms, Bloating | Phase 2 / Phase 3 | Completed | University of Maryland, Baltimore | 80 | 2014-12-01 | 2021-09-14 |
Abdominal Pain (1) · Constipation (1) · Dyspepsia (1) · Irritable Bowel Syndrome (1) · Mucopolysaccharidosis IV (1)
Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Signs and Symptoms, Digestive (2) · Carbohydrate Metabolism, Inborn Errors (1) · Colonic Diseases (1) · Colonic Diseases, Functional (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Connective Tissue Diseases (1) · Digestive System Diseases (1) · Gastrointestinal Diseases (1) · Genetic Diseases, Inborn (1) · Intestinal Diseases (1) · Lysosomal Storage Diseases (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1)
Pharmaceutical Preparations (1) · Rifaximin (1)
Mahidol University (1) · University of Maryland, Baltimore (1)
Thailand (1)
Chris D'Adamo, PhD (1) · Monthira Maneerattanaporn, M.D. (1) · Pubet Weeranawin, M.D. (1) · Somchai Leelakusolvong, M.D. (1) · Tanawat Geeratragool, M.D. (1)